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Citrus aurantium (bitter orange) is characterized by the presence of p-synephrine, an amine structurally 
and pharmacologically related to ephedrine. Besides the same adverse effects as ephedrine, nowadays 
it is believed that altered levels of p-synephrine can be associated to the occurrence of migraine and 
cluster headaches. Leaves and fruits of this species are highly commercialized in form of teas and herbal 
preparations, but without taking into account the risks associated with its use. This work describes a 
survey of teas and herbal preparations containing C. aurantium, commercialized in Porto Alegre (RS/
Brazil), in order to verify the presence of p-synephrine. Comparing with the mean amount available in 
the supermarkets, around 20% of the teas and 10% of the herbal preparations declared the presence of 
C. aurantium in their labels. In a sampling of 15 teas and 2 herbal preparations selected for the analysis, 
the presence of p-synephrine was characterized in all samples, with levels between 0.0040 to 0.2308%, 
leading to a caution that even being natural products, they are not free of adverse effects.
Uniterms: Citrus aurantium. P-synephrine/adverse effects. Bitter orange. Teas/analysis.
Citrus aurantium (laranjeira-azeda) é caracterizada pela presença de p-sinefrina, amina estrutural e 
farmacologicamente similar à efedrina. Além de poder causar efeitos adversos similares aos da efedrina, 
atualmente acredita-se que níveis endógenos alterados de p-sinefrina possam estar associados à causa 
da enxaqueca. Folhas e frutos desta espécie são largamente comercializados na forma de chá e em 
preparados de erva-mate, sem que sejam considerados os riscos associados ao seu uso. Neste sentido, 
este trabalho descreve uma pesquisa em chás e preparados de erva-mate comercializados em Porto 
Alegre, para verificar a presença de C. aurantium e p-sinefrina. Comparando com a quantidade média 
disponível nas prateleiras dos supermercados, cerca de 20% dos chás e 10% dos preparados de erva-
mate declaravam nos rótulos conter C. aurantium. De uma amostragem de 15 chás e 2 preparados de 
erva-mate selecionados para análise, em todos foi caracterizada a presença de p-sinefrina com níveis 
variando de 0,0040 a 0,2308%, levando ao alerta de que mesmo sendo naturais, estes produtos podem 
não ser destituídos de reações adversas. 
Unitermos: Citrus aurantium. p-Sinefrina/efeito adversos. Laranja-amarga. Chás/análise.
INTRODUCTION
Citrus aurantium L. (Rutaceae), a plant known as 
bitter orange, laranjeira-amarga or laranjeira-cavalo 
(Carvalho-Freitas, Costa, 2002; Kuster, Rocha, 2003), is 
chemically characterized by the presence of volatile oils, 
flavonoids, furanocoumarins and amines, especially p-
synephrine(Fugh-Berman, Myers, 2004). Popularly, it is 
used as digestive, sedative, anxiolytic (Carvalho-Freitas, 
Costa, 2002; Pultrini, Galindo, Costa, 2006), gastrointes-
tinal stimulating, general tonic (Bouchard et al., 2005), 
as seasoning in culinary (Fugh-Berman, Myers, 2004), 
aromatizing and in perfumery (Rogers, 1981). Some of 
these uses, as sedative and anxiolytic, present scientific 
support (Rogers, 1981; Carvalho-Freitas, Costa, 2002; 
Pultrini, Galindo, Costa, 2006).
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Currently, the use of C. aurantium is very diffused in 
stimulant, slimmer and thermogenic preparations (Linck, 
Thiesen, Leal, 2006), and in products commercialized as 
“dietary supplements” (Calapai et al., 1999; Bouchard et 
al., 2005; Firenzuoli, Gori, Calapai, 2005), due to pre-
sence of p-synephrine, an adrenergic amine structurally 
and pharmacologically similar to ephedrine. This use 
dissemination was stimulated by the Food and Drug Ad-
ministration (FDA) prohibition of ephedrine containing 
products commercialization, occurred the in 2004 April 
(Bent, Padula, Neuhaus, 2004; Bouchard et al., 2005) as a 
consequence of the clinical association between its use and 
hypertension, ischemia, cardiac and psychiatric problems 
(Fugh-Berman, Myers, 2004; Bouchard et al., 2005). Thus, 
appeared the “ephedra-free” products, whose formula do 
not contain ephedrine anymore, but extracts of C. auran-
tium, standardized as p-synephrine.
The substitution of ephedrine for p-synephrine was 
based on the hypothesis of specific stimulation of b3-
adrenergics receptors. As a matter of fact, when stimulated, 
these receptors cause increase in metabolic rate, leading 
to lipolysis stimulation and burning of calories (Kalman 
et al., 2000). However, there is no scientific proof that 
p-synephrine, or extracts of C. aurantium, effectively 
promote body weight decrease in humans (Bent, Padula, 
Neuhaus, 2004).
Despite the information respecting the utilization of 
C. aurantium as thermogenic agent being quite limited, it 
is well established in the literature that, just as ephedrine, 
the p-synephrine acts as on b-adrenergic, as on a receptors 
(Fugh-Berman, Myers, 2004; Arbo et al., 2008), and could 
cause similar adverse effects, which could be pronounced 
when associated to caffeine and salicin (Dulloo, Miller, 
1987; Daly, Krieger, Dulloo, 1993; Bray, Ryan, 1997; 
Haller, Jacob, Benowitz, 2004; Bouchard et al., 2005), 
substances generally present in commercial preparations. 
The association of citric species containing p-
synephrine with mate or yerba maté is a worrying fact, 
because it is known that the association of p-synephrine 
with a stimulant, such as the caffeine present in yerba maté, 
could bring more pronounced adverse effects (Bouchard et 
al., 2005). In human, effects such as tachycardia, cardiac 
arrhythmia, acute myocardial infarction, syncope and ce-
rebral ischemia were reported after use of dietary supple-
ments containing p-synephrine and, in one of the ischemia 
cases, there was association with caffeine (Bouchard et al., 
2005; Firenzuoli, Gori, Calapai, 2005). 
The p-synephrine and its biogenetic precursors, 
tyramine and octopamine, are called trace amines due to 
their low endogenous quantity (D’Andrea et al., 2004b). 
Currently, it is believed that metabolism disorders of these 
amines are associated with migraine and cluster headaches 
(D’Andrea et al., 2004a, b). Therefore, the consumption of 
food rich in these amines, such as cheese, wine, chocolate, 
in natura citric fruits, juices and teas, could accentuate the 
picture of people suffering cephalea. Studies demonstrate 
also that altered basal levels of trace amines are related 
with neurological and psychiatric pathologies, such as 
schizophrenia, depression, attention deficit, epilepsy, che-
mical dependence, phenylketonuria and in the neurodege-
nerative diseases of Parkinson and Alzheimer (Branchek, 
Blackburn, 2003; D’Andrea et al., 2003; D’Andrea et 
al., 2004a, b; Aridon et al., 2004; Berry, 2004; Shimazu, 
Miklya, 2004; Lewin, 2006).
In this context, and based on the commercializa-
tion of teas and yerba maté as food and soft drinks, the 
objective of this work was to bring a lifting of teas and 
yerba maté preparations containing citric species in their 
compositions, available in supermarkets of Porto Alegre/




Samples of 15 teas and 2 preparations of yerba 
maté (Ilex paraguariensis) were selected for analysis and 
purchased in a supermarkets network, in the city of Porto 
Alegre (RS, Brazil). The selection criteria took into ac-
count the trademark (it was attempted to acquire, at least, 
a representative of every trademark), the indication (stimu-
lants) and the fact to be a tea said ‘citric’ (some aromatic 
teas of non-citric flavors, even containing C. aurantium, 
did not participate in the sampling). A p-synephrine stan-
dard (99% of purity) was acquired from Sigma Chemical 
Co. (St. Louis, USA).
Extraction
Approximately 4 g of vegetal material were wei-
ghed into a conic test tube of 15 mL (Falcon type) and 
2 extractions were developed with 4 mL of methanol 
every one, by stirring during 20 minutes, followed by 
centrifugation of 15 minutes at 3000 rpm. The super-
natants were assembled, and the extract were lead to 
dryness in double boiler within a glass capsule, and the 
residue resuspended in small amount of methanol. For the 
verification of p-synephrine presence, the extracts were 
initially submitted to thin layer chromatography (TLC) 
and them to a high performance liquid chromatography 
with ultraviolet detection (HPLC/UV)
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TABLE I – Listing of samples of teas containing Citrus aurantium, commercialized in supermarkets of Porto Alegre and analyzed 
respecting to presence of p-synephrine (p-SIN)  
Professed composition in the product label p-SIN (%)
1. Scrubbed leaves of orange tree (C. aurantium). 0.0961
2. Leaves of orange tree (C. aurantium). 0.0046
3. Leaves of sweet lime tree (C. aurantium). 0.0132
4. Flowers of dog rose (R. canina), fruits of dehydrated apple tree (P. malus), peel of fruits from orange tree (C. 
aurantium), peel of fruits from lime tree (C. limonum) and natural flavor of tangerine.
0.0052
5. Flowers and fruits of dog rose (R. canina), flowers of hibiscus (H. sabdariffa) peels of fruits from apple tree (P. 
malus), peel of fruits from orange tree (C. aurantium), fruits of raspberry (R. idaeus) and natural flavor of orange.
0.0040
6. Fruits from apple tree (P. malus), fruits of dog rose (R. canina), peel of fruits from orange tree (C. aurantium), 
leaves of lemon grass (C. citratus), flowers of hibiscus (H. sabdariffa), root of chicory (C. intybus), acidulating 
citric acid and flavoring.
0.0063
7. Flowers of dog rose (R. canina), apple (P. malus), flowers of hibiscus (H. sabdariffa), leaves of lemon grass 
(C. citratus), peels of fruits from orange tree (C. aurantium), peels of lemon (C. limonum), flavor identical to 
natural lemon and acidulating citric acid (INS 330).
0.0112
8. Pup of apple (P. malus), flowers of hibiscus (H. sabdariffa), leaves of barbed wire grass (C. citratus), peels of 
sweet orange (C. aurantium), leaves and other parts of spearmint (M. arvensis). Lemon, orange and pineapple 
taste natural flavor.
0.0042
9. Fruits from apple tree (P. malus), fruits from strawberry (F. vesca), fruits from orange tree (C. aurantium), 
flowers of hibiscus (H. sabdariffa), leaves of lemon grass (C. citratus) and apple flavor.
0.0135
10. Dehydrated fruits from orage tree (C. aurantium), leaves of lemon grass (C. citratus), roots of chicory (C. 
intybus), peel of fruits from lemon tree (C. limonum), flowers of hibiscus (H. sabdariffa) and leaves of yerba 
maté (I. paraguayensis).
0.0277
11. Leaves of spearmint (M. piperita), leaves of lemon grass (C. citratus), fruits from apple tree (P. malus), flowers 
and fruits of dog rose (R. canina), lemon peel (C. limonum), rhizome from ginger (Z. officinalis), orange peel (C. 
aurantium), flowers of hibiscus (H. sabdariffa), ascorbic acid (Vit. C), root of chicory (C. intybus), acidulating 
citric acid and aromatizing.
0.0076
12. Fruits of national anise (F. vulgare), leaves of boldu (P. boldo), orange peel (C. aurantium), flowers of hibiscus 
(H. sabdariffa), leaves and twigs of mint (M. piperita), leaves of lemon grass (C. citratus), acidulating citric 
acid and aromatizing identical to natural flavor of pineapple and banana.
0.0156
13. Fruits of apple tree (P. malus), flowers of hibiscus (H. sabdariffa), leaves of gorse (B. genistelloides), fruits of 
national anise (F. vulgare), leaves of boldu (P. boldus), orange peel (C. aurantium), fruits of silvester rose (R. 
canina) and aromatizing.
0.0092
14. Fruits of apple tree (P. malus), fruits of silvester rose (R. canina), leaves of black tea (C. sinensis), peel of 
cinnamon (C. zeylanicum), peel of sweet orange (C. aurantium flowers of hibiscus (H. sabdariffa), root of 
chicory (C. intybus), leaves of lemon grass (C. citratus), flowers of carnation (S. aromaticum), acidulating 
citric acid and aromatizing.
0.0136
15. Fruits of fennel (F. vulgare), yerba maté (I. paraguayensis), peel of fruits from sweet orange (C. aurantium), 
peel of fruits and flowers from lemon (C. limonun) and peel of cinnamon (C. zeylanicum).
0.0088
16. Leaves of lemon grass (C. citratus), leaves of boldu (P. boldus), leaves and twigs of mint (M. arvensis), orange 
peels (C. aurantium).
0.0178
17. Yerba maté (I. paraguayensis), orange peels (C. aurantium), leaves and other parts of mint twigs (M. piperita), 
flowers of camomile (M. recutita) and leaves of lemon grass (C. citratus).
0.2308
Thin layer chromatography (TLC)
The samples were applied in a silica gel GF254 plate, 
together with standard of p-synephrine, utilizing as eluent 
butanol:acetic acid:water (4:1:2.2; v:v:v - Rf 0.62-0.65) 
and ninhydrin:butanol:acetic acid (30:10:0.3; m/v/v), as 
chromogenic agent, followed by warming at 100 °C for 
10 minutes.
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Ultraviolet high performance liquid 
chromatography (HPLC/UV)
The samples were diluted in the proportion 1:12 
in water, filtered through a membrane with pores sized 
0.45 mm (Millipore, Bedford, USA) and injected into a 
high performance liquid chromatograph (Knauer, Berlin, 
Germany) equipped with a pump model K 1001, online 
degasser model K 5004, manual injector with loop of 20 
µl, besides a detector UV/VIS model K 2501 with EURO-
CHROM 2000 SOFTWARE®, 2.05 for Windows (Knauer, 
Berlin, Germany). The chromatographic separation was 
developed utilizing a reverse phase column C18 Euros-
pher-100®, 150 x 4 mm with pore sized 5 µm of particle 
diameter (pd), with pre-column Eurospher-100
®, 5 x 4 
mm, 5 mm of particle diameter. The peaks were detected 
at 220 nm. As mobile phase, mixings of acetonitrile:wate
r:trifluoroacetic acid (TFA) in the proportion 5:95:0.01, as 
phase A; and acetonitrile:TFA (100:0.01) as phase B were 
utilized, in flow of 0.6 mL/min. The program of linear 
gradient employed was of 100 – 59% of A (8 minutes); 
100% of B (9 minutes), and then the system remained in 
isocratic mode 100% of A during 3 minutes, with total 
analysis time of 12 minutes. The volume of injection was 
of 20 µL. The chromatographic separation was developed 
at room temperature. The peak of interest was identified 
by comparison to p-synephrine standard retention time 
(4 minutes). The method was previously validated in our 
laboratory (Arbo et al., 2008).
RESULTS AND DISCUSSIONS
This study was based on the fact that for long time, 
plants have been indiscriminately used by population, 
associated to the fake idea that everything that is natural, 
could not harm the health (Simões, 2004). Within this con-
text are the teas utilized not only for medicinal purposes, 
but also as hot and cool beverages, and the preparations 
of yerba maté that are very appreciated by gaucho people, 
whom use chimarrão (infusion based on yerba maté - Ilex 
paraguariensis St. Hill.) as part of their culture.
Great quantity of products containing citric species 
(21 teas and 2 yerba maté preparations) was found, the 
majority named “orange” and having no specification 
about the citric species, being all of them classified as C. 
aurantium. The products containing C. aurantium totali-
zed about 20% of teas and 10% of yerba maté preparations 
available at supermarkets counters.
From this lifting, 15 teas and 2 yerba maté prepa-
rations (n=17) were selected for analysis respecting the 
presence of p-synephrine, and forwarded for selection by 
TLC and further confirmation by HPLC/UV, being eviden-
ced the presence of p-synephrine in all analyzed samples, 
with amounts varying from 0.0040 up to 0.2308% (Table 
I), similar to already reported concentrations for species 
of Citrus occurring in Southern Brazil (Arbo et al., 2008).
In the developed lifting, it was observed that some 
teas (included in the sampling) are indicated as stimulants, 
being suggested to be ingested at morning “to help to wake 
up”; or as metabolism accelerator in order “to help to 
slim”, and even associated to vitamin C (ascorbic acid) “to 
help to fight against the somnolence caused by influenza 
and cold”. However, the teas are not considered medica-
tions by legislation, but food; not existing so a specific 
raw material control as it does exist for phytotherapeutic 
medications (Brasil, 2004).
CONCLUSION
Face to these data, it is evidenced the presence of 
p-synephrine in citric teas and yerba maté preparations 
containing C. aurantium, commercialized in Porto Alegre 
(RS) and analyzed in this study. Therefore, it is necessary 
to adopt some caution when consuming products contai-
ning great amounts of p-synephrine, as there are adverse 
event reports associated to its use and lack of scientific 
proof for their supposed therapeutic effects.
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